THE Therapeutic Goods Administration (TGA) has advised that Homart Pharmaceuticals is recalling specific batches of its product, SpringLeaf Fat Clear, due to compliance issues.
Firstly, the product label does not bear a mandatory phenylalanine warning.
The product information also recommends a daily dose that far exceeds the permitted limit for poliglusam intake.
Consumers are advised to contact Homart customer service - batch details are available on the TGA WEBSITE.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jul 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 25
